| 09/21/2026 3:01 PM | Sangamo Therapeutics (1001233) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/08/2026 3:06 PM | Sangamo Therapeutics (1001233) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/28/2026 3:05 PM | Sangamo Therapeutics (1001233) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/17/2026 4:10 PM | Sangamo Therapeutics (1001233) Filer | Form NT 10-Q | |
| 08/14/2026 9:26 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Sangamo Therapeutics (1001233) Subject | Form SCHEDULE 13G/A | |
| 08/12/2026 8:36 PM | Sangamo Therapeutics (1001233) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/20/2026 3:44 PM | Sangamo Therapeutics (1001233) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/01/2026 3:01 PM | Sangamo Therapeutics (1001233) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/23/2026 3:42 PM | Sangamo Therapeutics (1001233) Filer | Form 8-K/A | |
| 06/23/2026 7:45 AM | Sangamo Therapeutics (1001233) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 6:30 PM | Macrae Sandy (1675687) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SGMO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sangamo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/27/2026 6:30 PM | Sangamo Therapeutics (1001233) Issuer Willoughby Scott B. (1877368) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 6:30 PM | Dubois-Stringfellow Nathalie (1947007) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 6:30 PM | Jain Nikunj (2089213) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 6:30 PM | Davis Gregory D (2041855) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 10:27 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Sangamo Therapeutics (1001233) Subject | Form SCHEDULE 13G | |
| 04/29/2026 7:37 AM | Sangamo Therapeutics (1001233) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/23/2026 3:05 PM | Dubois-Stringfellow Nathalie (1947007) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/23/2026 3:07 PM | Davis Gregory D (2041855) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:01 PM | Davis Gregory D (2041855) Reporting Sangamo Therapeutics (1001233) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/06/2026 6:08 AM | Dubois-Stringfellow Nathalie (1947007) Reporting Sangamo Therapeutics (1001233) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/03/2026 3:15 PM | Sangamo Therapeutics (1001233) Issuer Willoughby Scott B. (1877368) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 3:15 PM | Macrae Sandy (1675687) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 3:15 PM | Davis Gregory D (2041855) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 3:15 PM | Jain Nikunj (2089213) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 3:15 PM | Dubois-Stringfellow Nathalie (1947007) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 8:40 PM | Davis Gregory D (2041855) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 8:40 PM | Jain Nikunj (2089213) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 8:40 PM | Sangamo Therapeutics (1001233) Issuer Willoughby Scott B. (1877368) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 8:40 PM | Macrae Sandy (1675687) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 8:40 PM | Dubois-Stringfellow Nathalie (1947007) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/04/2026 7:31 AM | Sangamo Therapeutics (1001233) Filer | Form 424B5 | |
| 02/04/2026 7:35 AM | Sangamo Therapeutics (1001233) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/03/2026 7:55 AM | Sangamo Therapeutics (1001233) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/03/2026 8:07 AM | Sangamo Therapeutics (1001233) Subject | Form FWP | |
| 01/26/2026 3:06 PM | Dubois-Stringfellow Nathalie (1947007) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:08 PM | Davis Gregory D (2041855) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:10 PM | Macrae Sandy (1675687) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:12 PM | Sangamo Therapeutics (1001233) Issuer Willoughby Scott B. (1877368) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:13 PM | Duraibabu Prathyusha (1779092) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:14 PM | Jain Nikunj (2089213) Reporting Sangamo Therapeutics (1001233) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Your book is inside (Ad) Blane Markham and the Markham Trading Team are giving readers a limited window to download their options strategy guide, titled How To Turn $100 Options Into $1,000 Gains, before it moves behind a paywall.
The guide walks through options trading concepts the team uses in its own research and education materials.
Once the paywall goes up, free access ends for good. Download your free copy of the options guide now |